Robotic Rehabilitation for Stroke Survivors
Launched by STATE UNIVERSITY OF NEW YORK AT BUFFALO · Jun 8, 2022
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Robotic Rehabilitation for Stroke Survivors," is exploring how robotic therapy can help people who have had a stroke regain their ability to perform everyday tasks. The focus is on adults aged 65 to 74 who are dealing with long-term effects of a stroke that have impacted their ability to move their arms. If someone had a stroke and is still struggling with their arm movements but can follow simple instructions during training, they might be eligible to participate.
The study is currently not recruiting participants, but once it starts, those who join can expect to undergo robotic therapy designed to improve their arm function. This could potentially help them become more independent in daily activities. It's important to note that individuals who have not lost the use of their arms due to a stroke won't qualify for this study. Overall, this research aims to find out if robotic rehabilitation can make a real difference in the lives of stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults with chronic stroke, which affected their upper limb motor functions
- • Adults could able to understand the verbal cues during the training
- Exclusion Criteria:
- • Adults with chronic stroke, who did not lose their upper limb motor functions
About State University Of New York At Buffalo
The State University of New York at Buffalo (SUNY Buffalo) is a prominent research institution dedicated to advancing healthcare through innovative clinical trials and studies. Renowned for its commitment to academic excellence and interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore novel therapeutic approaches and enhance patient outcomes. SUNY Buffalo's clinical trials encompass a wide range of medical disciplines, driven by a mission to translate research discoveries into practical applications that benefit diverse populations. With a focus on ethical standards and rigorous methodologies, the university fosters an environment that supports cutting-edge research while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Buffalo, New York, United States
Patients applied
Trial Officials
Jiyeon Kang
Principal Investigator
University at Buffalo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials